Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo
- 16 September 2002
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 20 (10) , 999-1005
- https://doi.org/10.1038/nbt738
Abstract
A major limitation of adenovirus-mediated gene therapy for inherited diseases is the instability of transgene expression in vivo, which originates at least in part from the loss of the linear, extrachromosomal vector genomes. Herein we describe the production of a gene-deleted adenovirus–transposon vector that stably maintains virus-encoded transgenes in vivo through integration into host cell chromosomes. This system utilizes a donor transposon vector that undergoes Flp-mediated recombination and excision of its therapeutic payload in the presence of the Flp and Sleeping Beauty recombinases. Systemic in vivo delivery of this system resulted in efficient generation of transposon circles and stable transposase-mediated integration in mouse liver. Somatic integration was sufficient to maintain therapeutic levels of human coagulation Factor IX for more than six months in mice undergoing extensive liver proliferation. These vectors combine the versatility of adenoviral vectors with the integration capabilities of a eukaryotic DNA transposon and should prove useful in the treatment of genetic diseases.Keywords
This publication has 49 references indexed in Scilit:
- Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vectorProceedings of the National Academy of Sciences, 2001
- Chromosomal Integration Pattern of a Helper-Dependent Minimal Adenovirus Vector with a Selectable Marker Inserted into a 27.4-Kilobase Genomic StufferJournal of Virology, 2001
- Extrachromosomal Recombinant Adeno-Associated Virus Vector Genomes Are Primarily Responsible for Stable Liver Transduction In VivoJournal of Virology, 2001
- Regulated transposition of a fish transposon in the mouse germ lineProceedings of the National Academy of Sciences, 2001
- Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon systemNature Genetics, 2000
- High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels ofα1-Antitrypsin with Negligible ToxicityHuman Gene Therapy, 1998
- Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicityNature Genetics, 1998
- A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signalProceedings of the National Academy of Sciences, 1996
- Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.Proceedings of the National Academy of Sciences, 1994
- Gene therapy: adenovirus vectorsCurrent Opinion in Genetics & Development, 1993